Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D After Living Donor Liver Transplantation

Overview

Journal Metabolites

Publisher MDPI

Date 2022 May 28

PMID 35629892

Authors

Shu-Hsien Lin

Chih-Chi Wang

Kuang-Tzu Huang

Kuang-Den Chen

Li-Wen Hsu

Hock-Liew Eng

King-Wah Chiu

Affiliations

Soon will be listed here.

Abstract

Background: Most cases of advanced liver diseases are associated with low serum 25-hydroxyvitamin D and vitamin D deficiency. This phenomenon may occur in living donor liver transplantation (LDLT).

Aims: We conducted this study to explore the interplay between VDR and CYP2R1 in liver graft and compared our findings with the pathological interpretation of serum 25(OH)D concentration.

Methods: In total, 60 patients received liver graft biopsy after LDLT and were separated (1:1) into two groups: graft rejection group and graft non-rejection group. We extracted both of the recipients' and donors' serum DNA to investigate the vitamin D receptor (VDR) rs2228530 and CYP2R1 rs10741657 single nucleotide polymorphisms (SNPs) using real-time polymerase chain reaction. We also extracted DNA from liver graft tissues to explore the genetic alleles of VDR rs2228530 and CYP2R1 rs10741657 after LDLT. Serum biochemistry profile and 25(OH)D concentrations were measured before and after LDLT.

Results: There were no significant differences in serum VDR rs2228530 and CYP2R1 rs10741657 genetic alleles between recipients and donors. The percentage of genetic modification was 33.4% (10/30) for the rejection and non-rejection groups in VDR rs2228530, and 66.7% (20/30) for both groups in CYP2R1 rs10741657. Serum 25(OH)D concentrations were significantly lower after LDLT D30 than that before LDLT in the rejection ( = 0.0001) and non-rejection graft pathology ( = 0.0017) groups.

Conclusions: The presence of low serum 25(OH)D concentrations after LDLT suggested that post-transplant low serum 25(OH)D concentrations may develop with the homogenous phenomenon of VDR rs2228530 and CYP2R1 rs10741657 genetic modifications in recipients regardless of graft pathology.

Citing Articles

Proteomics and Metabolomics in Biomedicine.

Santorelli L, Caterino M, Costanzo M Int J Mol Sci. 2023; 24(23).

PMID: 38069240 PMC: 10706996. DOI: 10.3390/ijms242316913.

Insights into the liver-eyes connections, from epidemiological, mechanical studies to clinical translation.

Wu J, Duan C, Yang Y, Wang Z, Tan C, Han C J Transl Med. 2023; 21(1):712.

PMID: 37817192 PMC: 10566185. DOI: 10.1186/s12967-023-04543-3.

References

Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber T, Trauner M . Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 2012; 32(5):845-51. DOI: 10.1111/j.1478-3231.2011.02735.x. View

Chiu K, Nakano T, Hu T, Tseng H, Cheng Y, Jawan B . Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation. Eur J Clin Invest. 2011; 42(4):352-6. DOI: 10.1111/j.1365-2362.2011.02589.x. View

Chiu K, Nakano T, Chen K, Hsu L, Lai C, Huang C . Cytochrome P450 in living donor liver transplantation. J Biomed Sci. 2015; 22:32. PMC: 4432787. DOI: 10.1186/s12929-015-0140-4. View

Jamka M, Arslanow A, Bohner A, Krawczyk M, Weber S, Grunhage F . Effects of Gene Variants Controlling Vitamin D Metabolism and Serum Levels on Hepatic Steatosis. Digestion. 2018; 97(4):298-308. DOI: 10.1159/000485180. View

Zhou Q, Li L, Chen Y, Zhang J, Zhong L, Peng Z . Vitamin D supplementation could reduce the risk of acute cellular rejection and infection in vitamin D deficient liver allograft recipients. Int Immunopharmacol. 2019; 75:105811. DOI: 10.1016/j.intimp.2019.105811. View

Manco M, Ciampalini P, Nobili V . Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology. 2010; 51(6):2229. DOI: 10.1002/hep.23724. View

Xuan Hoan N, Khuyen N, Binh M, Giang D, Van Tong H, Quoc Hoan P . Association of vitamin D deficiency with hepatitis B virus - related liver diseases. BMC Infect Dis. 2016; 16(1):507. PMC: 5034475. DOI: 10.1186/s12879-016-1836-0. View

Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer H . Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29(6):726-76. PMC: 2583388. DOI: 10.1210/er.2008-0004. View

Chiu K, Nakano T, Chen K, Hu T, Lin C, Hsu L . Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing Analysis. Biomed Res Int. 2018; 2018:1826140. PMC: 5857340. DOI: 10.1155/2018/1826140. View

10.

Backstedt D, Pedersen M, Choi M, Seetharam A . 25-Vitamin D levels in chronic hepatitis C infection: association with cirrhosis and sustained virologic response. Ann Gastroenterol. 2017; 30(3):344-348. PMC: 5411385. DOI: 10.20524/aog.2017.0120. View

11.

Martucci G, Volpes R, Panarello G, Tuzzolino F, Di Carlo D, Ricotta C . Vitamin D levels in liver transplantation recipients and early postoperative outcomes: Prospective observational DLiverX study. Clin Nutr. 2020; 40(4):2355-2363. DOI: 10.1016/j.clnu.2020.10.027. View

12.

Chiu K, Goto S, Nakano T, Hu T, Chen D, Huang K . Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation. Liver Int. 2018; 38(12):2287-2293. DOI: 10.1111/liv.13920. View

13.

Chiu K, Chen Y, de Villa V, Wang C, Eng H, Wang S . Characterization of liver enzymes on living related liver transplantation patients with acute rejection. Hepatogastroenterology. 2005; 52(66):1825-7. View

14.

Reese P, Bloom R, Feldman H, Huverserian A, Thomasson A, Shults J . Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int. 2011; 32(2):287-96. PMC: 4566950. DOI: 10.1111/j.1478-3231.2011.02638.x. View

15.

Barchetta I, Angelico F, Ben M, Baroni M, Pozzilli P, Morini S . Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011; 9:85. PMC: 3148980. DOI: 10.1186/1741-7015-9-85. View

16.

Barchetta I, Carotti S, Labbadia G, Gentilucci U, Onetti Muda A, Angelico F . Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology. 2012; 56(6):2180-7. DOI: 10.1002/hep.25930. View

17.

Chiu K, Nakano T, Hu T, Chen K, Hsu L, Eng H . Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation. Biomed Res Int. 2018; 2018:4508085. PMC: 5884236. DOI: 10.1155/2018/4508085. View

18.

Chiu K, Nakano T, Chen K, Lin C, Hu T, Goto S . Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation. PLoS One. 2016; 11(6):e0156846. PMC: 4898820. DOI: 10.1371/journal.pone.0156846. View

19.

Chiu K, Nakano T, Chen K, Lai C, Hsu L, Chiu H . Pyrosequencing to identify homogeneous phenomenon when using recipients/donors with different CYP3A5*3 genotypes in living donor liver transplantation. PLoS One. 2013; 8(8):e71314. PMC: 3738598. DOI: 10.1371/journal.pone.0071314. View